Trump''s team makes a deal with a drug company and changes rules for medical marijuana
Introduction
President Trump said his team made a deal with a drug company called Regeneron. This is the 17th deal. Also, the government changed the rules for medical marijuana.
Main Body
The deal with Regeneron says the price of a drug called Praluent will go down. It was $537. Now it is $225. People can buy it on the TrumpRx website. In the future, Regeneron must sell its drugs in the US for the same low price as in other countries. Regeneron will also spend $27 billion to make new drugs in the US. The FDA said yes to a new medicine called Otarmeni. It is the first medicine of its kind. This is the 17th deal. Before this, 16 other drug companies made similar deals. These companies include Pfizer, AstraZeneca, and others. The details of each deal are secret. Some deals are not finished yet. A man named Kennedy explained how President Trump talks about price cuts. Kennedy said Trump uses a different way to count. For example, if a drug costs $600 and then costs $10, Trump says it is a 600% cut. But that is not normal math. In a different action, the government changed the rules for medical marijuana. It moved medical marijuana from a strict group to a less strict group. This does not make it legal under federal law. But it gives a tax break to people who sell medical marijuana. It also makes it easier to study marijuana.
Conclusion
This deal ends the first group of talks with big drug companies. But we do not know the full effect because the deals are secret. The new rules for medical marijuana are a big change, but it is still not legal under federal law. These actions show the government is trying to change drug prices and drug rules.